Global Breast Cancer Liquid Biopsy Market

Breast Cancer Liquid Biopsy Market Size, Share, Growth Analysis, By Circulating Biomarkers (Circulating Tumor Cells, Circulating Cell-Free Dna), By Application (Early Detection/Screening, Diagnosis), By Region - Industry Forecast 2026-2033

Report ID: SQMIG35J2098 | Region: Global | Published Date: November, 2025
Pages: 157 |Tables: 90 |Figures: 76

To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Breast Cancer Liquid Biopsy Market size was valued at USD 511.7 Million in 2024 and is poised to grow from USD 627.85 Million in 2025 to USD 3225.62 Million by 2033, growing at a CAGR of 22.7% during the forecast period (2026–2033).

    The global breast cancer liquid biopsy market was witnessing intense competition among key players. Companies in this space were continuously focusing on technological advancements, strategic collaborations, and product innovations to gain a competitive edge. The market was characterized by a diverse range of liquid biopsy solutions aimed at detecting breast cancer-related biomarkers in a non-invasive manner. Additionally, the growing emphasis on early cancer detection and personalized medicine was fueling the demand for liquid biopsy products, driving further competition and market growth. 'F. Hoffmann-La Roche Ltd ', 'Bio-Rad Laboratories Inc. ', 'Illumina Inc. ', 'Guardant Health Inc. ', 'QIAGEN ', 'Biocept Inc. ', 'Thermo Fisher Scientific ', 'Adaptive Biotechnologies ', 'Myriad Genetics ', 'Fluxion Biosciences Inc. ', 'Biodesix ', 'Exosome Diagnostics Inc. ', 'Epic Sciences ', 'PapGene ', 'Pathway Genomics (OME Care) ', 'Agena Bioscience ', 'MDxHealth ', 'Janssen Diagnostics ', 'Abbott '

    The increasing adoption of liquid biopsy techniques is a significant driver in the global breast cancer liquid biopsy market. Compared to traditional tissue biopsies, liquid biopsies allow for the analysis of circulating tumor cells (CTCs), cell-free DNA (cfDNA), and other biomarkers present in blood samples, enabling healthcare professionals to make more informed treatment decisions. Additionally, liquid biopsy has the potential to identify resistance mutations and minimal residual disease, which can aid in personalized treatment strategies, leading to improved patient outcomes and reduced healthcare costs.

    There was a growing emphasis on non-invasive diagnostic methods, such as liquid biopsies, for early detection and monitoring of breast cancer.

    North America led the way with a strong presence of key market players, advanced healthcare infrastructure, and growing adoption of liquid biopsy technologies. Europe demonstrated significant growth due to increased awareness, supportive government initiatives, and rising research and development activities. The Asia-Pacific region exhibited substantial potential, driven by a large patient pool, expanding healthcare expenditure, and increasing focus on personalized medicine. Latin America and the Middle East/Africa regions also experienced a gradual uptick in liquid biopsy adoption, with improving healthcare facilities and a greater emphasis on cancer diagnostics.

    Related Reports

    Liquid Biopsy Market
    Buy Now GET FREE SAMPLE
    Breast Biopsy Market
    Buy Now GET FREE SAMPLE
    Breast Cancer Diagnostics Market
    Buy Now GET FREE SAMPLE
    Breast Cancer Market
    Buy Now GET FREE SAMPLE
    Vacuum-Assisted Breast Biopsy Device Market
    Buy Now GET FREE SAMPLE
    Cancer Diagnostics Market
    Buy Now GET FREE SAMPLE
    Breast Imaging Technologies Market
    Buy Now GET FREE SAMPLE
    Next Generation Cancer Diagnostics Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Breast Cancer Liquid Biopsy Market

    Report ID: SQMIG35J2098

    $5,300
    BUY NOW